Overview of Dr. Berman
Dr. Ellin Berman is a hematologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from Harvard Medical School and has been in practice 40 years. Dr. Berman accepts several types of health insurance, listed below. She is one of 61 doctors at Memorial Sloan Kettering Cancer Center and one of 8 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Hematology. She has more than 100 publications and over 500 citings.
Office
530 East 74th Street
New York, NY 10021
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1980 - 1983
- Boston University Medical CenterResidency, Internal Medicine, 1977 - 1980
- Harvard Medical SchoolClass of 1977
Certifications & Licensure
- FL State Medical License 2021 - Present
- NJ State Medical License 2024 - 2025
- NY State Medical License 1982 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- Most Compassionate Doctor American Registry
Clinical Trials
- Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia Start of enrollment: 2002 Apr 01
- Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Start of enrollment: 2003 Dec 01
- Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors Start of enrollment: 2006 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 459 citationsThe price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML expertsCamille N. Abboud, Ellin Berman, Adam D. Cohen, Jorge E. Cortes, Daniel J. DeAngelo
Blood. 2013-05-30 - 722 citationsGilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AMLAlexander E. Perl, Giovanni Martinelli, Jorge E. Cortes, Andreas Neubauer, Ellin Berman
The New England Journal of Medicine. 2019-10-30 - 276 citationsResults of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute mye...Ellin Berman, G. Heller, J Santorsa, S McKenzie, Timothy Gee
Blood. 1991-04-15
Abstracts/Posters
- Overcoming Adaptive Therapy Resistance in AML By Targeting Immune Response PathwaysEllin Berman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Emerging Mutations at Relapse in Patients with FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia Who Received Gilteritinib Therapy in the Phase 3 Admiral TrialCl...Ellin Berman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- Pregnancy Considerations for Patients with Chronic Myeloid LeukemiaApril 28th, 2023
- An Interview with Associate Professor Stavroula Kousteni (Part One)August 8th, 2016
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPOHumana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: